Product Information

LABETALOL HCL 100 MG TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.0807 per EA under NDC 71930003552. Its NADAC has been published 357 times since Jul 24, 2019.

FDA first approved this application on Feb 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LABETALOL HCL 100 MG TABLET

Labetalol Hydrochloride
$0.0807per EA

Strength

100 mg/1

Manufacturer

Eywa Pharma Inc

NDC

71930003552

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

5/20/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207863

FDA Approved

2/4/2019

TE Code

AB

On Market Since

5/24/2019

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for LABETALOL HCL 100 MG TABLET has been published 357 times since Jul 24, 2019, and over the history we have for it it has declined 51.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0807 per EA
All-time high$0.1647 (Aug 14, 2019)
All-time low$0.0789 (Mar 18, 2026)
52-week high$0.0852
52-week low$0.0789
Median price$0.1188
Average price$0.1184
Largest weekly change+34.4% (Jun 19, 2024)
Weeks tracked357
Tracking sinceJul 24, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

-2.7%

1Y

-5.2%

3Y

-26.6%

5Y

-46.7%

All

-51.0%

Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LABETALOL HCL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 100 MG TABLET, manufactured by Eywa Pharma Inc, is $0.0807 per EA (NDC 71930003552), effective May 20, 2026.

How has the price of LABETALOL HCL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for LABETALOL HCL 100 MG TABLET has declined 51.0%. It has been tracked across 357 weekly CMS publications since Jul 24, 2019.

What are the highest and lowest recorded NADAC prices for LABETALOL HCL 100 MG TABLET?

Since Jul 24, 2019, the NADAC for LABETALOL HCL 100 MG TABLET has ranged from a low of $0.0789 (Mar 18, 2026) to a high of $0.1647 (Aug 14, 2019), with a median of $0.1188 per EA.

Are there cheaper alternatives to LABETALOL HCL 100 MG TABLET?

12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LABETALOL HCL 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LABETALOL HCL 100 MG TABLET?

LABETALOL HCL 100 MG TABLET (NDC 71930003552) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.